MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 08-07-2024
Alimera Sciences ROE Ratio 2011-2026 | ALIM
Annual ROE Ratio Alimera Sciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -43.6 | 87.02 | 167.83 | 66.92 | 234.94 | -601.84 | -147.47 | -129.66 | -116.43 | -72.52 | 938.66 | -50.44 | -90.14 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 938.66 | -601.84 | 18.71 |
Quarterly ROE Ratio Alimera Sciences
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -67.3 | -32.5 | 33.65 | 62.73 | 109.68 | 123.55 | -154.94 | -462.52 | -359.35 | -119.58 | -111.83 | 174.41 | 77.91 | 54.68 | 125.32 | 188.21 | 269.64 | 246.14 | 119.4 | -77.99 | -338.28 | -555.99 | -604.41 | -513.09 | -384.62 | -147.47 | -122.21 | -122.92 | -131.24 | -129.66 | -147.2 | -116.93 | -122.78 | -116.43 | -95.94 | -104.23 | -69.32 | -74.03 | -31.22 | 5.53 | 335.52 | 638.78 | 625.0 | 588.62 | 244.37 | -36.93 | -63.12 | -75.52 | -84.36 | -65.84 | -26.18 | -20.85 | -18.8 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 638.78 | -604.41 | -31.74 |
ROE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aerie Pharmaceuticals
AERI
|
431.6 | - | - | $ 754 M |  USA |
 |
Canopy Growth Corporation
CGC
|
-122.76 | $ 1.14 | -1.73 % | $ 123 M |  Canada |
 |
Cronos Group
CRON
|
-4.28 | $ 2.63 | - | $ 1.38 B | Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
-162.53 | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3276.74 | - | 0.86 % | $ 117 M | USA |
 |
Catalent
CTLT
|
-28.94 | - | - | $ 11.5 B | USA |
 |
Agile Therapeutics
AGRX
|
88.64 | - | 10.11 % | $ 58.2 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-75.79 | - | - | $ 55.5 M | USA |
 |
Aurora Cannabis
ACB
|
-154.42 | $ 4.19 | -1.64 % | $ 86.3 M | Canada |
 |
DURECT Corporation
DRRX
|
-186.86 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
15.26 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
37.13 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
302.08 | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-50.54 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-98.17 | - | 2.45 % | $ 38.1 M | Canada |
 |
Emergent BioSolutions
EBS
|
-117.13 | $ 12.39 | 1.98 % | $ 634 M | USA |
 |
Athenex
ATNX
|
1589.72 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-66.13 | $ 21.56 | 0.07 % | $ 2.05 B |  France |
 |
Evolus
EOLS
|
-913.07 | $ 6.67 | -0.07 % | $ 414 M | USA |
 |
Harrow Health
HROW
|
-34.5 | $ 49.34 | -1.36 % | $ 1.61 B | USA |
 |
China Pharma Holdings
CPHI
|
-61.13 | $ 1.22 | -8.65 % | $ 21.3 M |  China |
 |
OrganiGram Holdings
OGI
|
-45.46 | $ 1.69 | -0.88 % | $ 402 M | Canada |
 |
Bausch Health Companies
BHC
|
57.93 | $ 6.96 | -0.43 % | $ 2.54 B | Canada |
 |
Lannett Company
LCI
|
92.26 | - | 1.15 % | $ 7.11 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
7.34 | - | - | $ 193 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.33 | $ 3.96 | -0.13 % | $ 55.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
0.33 | $ 5.14 | -0.77 % | $ 677 M | USA |
 |
Sundial Growers
SNDL
|
-88.87 | $ 1.64 | -0.61 % | $ 3.37 M | Canada |
 |
Pacira BioSciences
PCRX
|
-12.79 | $ 26.04 | -0.12 % | $ 1.2 B | USA |
 |
PetIQ
PETQ
|
0.96 | - | 1.64 % | $ 400 M | USA |
 |
Jupiter Wellness
JUPW
|
2273.74 | - | - | $ 33.6 M | USA |
 |
Perrigo Company plc
PRGO
|
-3.98 | $ 13.91 | -0.22 % | $ 1.91 B | USA |
 |
ProPhase Labs
PRPH
|
29.02 | $ 0.44 | -2.36 % | $ 6.97 M | USA |
 |
Rockwell Medical
RMTI
|
-39.64 | $ 0.81 | -0.96 % | $ 18.9 M | USA |
 |
Radius Health
RDUS
|
27.81 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
-22.63 | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
-115.74 | $ 4.79 | 5.63 % | $ 144 M | USA |
 |
OptiNose
OPTN
|
40.97 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
-240.53 | $ 9.08 | -1.3 % | $ 645 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-78.37 | $ 3.54 | -2.13 % | $ 4.39 M | USA |
 |
PLx Pharma
PLXP
|
-129.32 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
-90.86 | $ 5.76 | 0.96 % | $ 235 M | USA |
 |
SCYNEXIS
SCYX
|
91.88 | $ 0.63 | 3.22 % | $ 30.1 M | USA |
 |
Tricida
TCDA
|
-80993.58 | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
-43.81 | $ 8.97 | -0.54 % | $ 5.54 B | Canada |
 |
Veru
VERU
|
-116.97 | $ 2.13 | -1.84 % | $ 287 M | USA |
 |
TherapeuticsMD
TXMD
|
-35.09 | $ 1.63 | -0.61 % | $ 17 M | USA |
 |
Viatris
VTRS
|
9.86 | $ 12.52 | -0.2 % | $ 15.2 B | USA |
 |
cbdMD
YCBD
|
-7.78 | $ 1.37 | 0.37 % | $ 5.91 M | USA |